This website is for UK Healthcare Professionals only


September: Episode 3     Watch time: 15 min

Psoriasis in practice: BAD guideline updates

The third episode focuses on how dermatologists have been working with the recent BAD guideline updates in the clinic.2,3

Podcast Series Host

Dr Laura Savage

University of Leeds and Leeds

Teaching Hospitals NHS Trust

Podcast Guest Speakers

Rebecca Batchelor

Royal Devon and Exeter NHS Foundation Trust


Dr Hywel Cooper

Portsmouth Hospitals NHS Trust




JULY: Episode 1

Clinical trial spotlight - risankizumab and secukinumab head-to-head in plaque psoriasis

AUGUST: Episode 2

Psoriasis in the time of COVID-19: an era of virtual clinics?             

SEPTEMBER: Episode 3

Psoriasis in practice: BAD guideline updates                               

OCTOBER: Episode 4

BAD 2020: virtual congress highlights

NOVEMBER: Episode 5

Are all IL-23s the same?                    

DECEMBER: Episode 6

EADV 2020: congress highlights       


  1. SKYRIZI (risankizumab) Summary of Product Characteristics.
  2. Smith CH, et al. BJD 2020, Published: March 18, 2020. DOI:10.1111/bjd.19039.
  3. NCT03478787. (Accessed August 2020).

UK-RISN-210515 Date of Preparation: November 2021